Searches , social queries for ICRUCUMAB
Search references for ICRUCUMAB. Phrases containing ICRUCUMAB
See searches and references containing ICRUCUMAB!
Search references for ICRUCUMAB. Phrases containing ICRUCUMAB
See searches and references containing ICRUCUMAB!ICRUCUMAB
Monoclonal antibody
Icrucumab (IMC-18F1) is a human monoclonal antibody designed for the treatment of solid tumors. Icrucumab was developed by ImClone Systems Inc. It is
Icrucumab
Tricyclic antidepressant
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Amitriptyline
Antibodies from clones of the same blood cell
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Monoclonal_antibody
Monoclonal antibody against amyloid beta
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Donanemab
Monoclonal antibody against amyloid beta
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Lecanemab
Antibodies from non-human species made nearly identical to human ones
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Humanized_antibody
Chemical compound
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Bimagrumab
Pharmaceutical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Braegen-02
Chemical compound
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Caplacizumab
Primary male sex hormone
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Testosterone
Pharmaceutical drug
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Romosozumab
Monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Emicizumab
Monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Trevogrumab
Monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Bedinvetmab
Monoclonal antibody against amyloid beta
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Aducanumab
Pharmaceutical drug
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Evolocumab
Monoclonal antibody
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Amivantamab
Medication
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Marstacimab
Chemical compound
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Erenumab
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Dehydroepiandrosterone
Pharmaceutical biological monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Fremanezumab
Monoclonal antibody protein
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Gantenerumab
Medication
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Concizumab
Medication
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Bevacizumab
Pharmaceutical drug
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Alirocumab
Corticosteroid medication
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Dexamethasone
Peptide hormone
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Insulin
Monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Galcanezumab
Protein that stimulates red blood cell production
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Erythropoietin
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Fosgonimeton
Drug class
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Anti-amyloid_antibodies
Drugs that inhibit α-synuclein
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Anti-α-synuclein_drug
Human monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Denosumab
Mammalian protein found in humans
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
HER2
Chemical compound
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Bapineuzumab
Protein found in humans
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Insulin-like_growth_factor_1
Protein found in humans
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Brain-derived neurotrophic factor
Brain-derived_neurotrophic_factor
Monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Inclacumab
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Dehydroepiandrosterone sulfate
Dehydroepiandrosterone_sulfate
Medical usage of the prasterone compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Prasterone
Protein or other substance that stimulates cellular proliferation
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Growth_factor
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Asciminib
Group of signal transduction pathways involved in embryonic development
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Wnt_signaling_pathway
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Imatinib
Veterinary medication
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Relfovetmab
Monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Abelacimab
Transmembrane protein
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Epidermal growth factor receptor
Epidermal_growth_factor_receptor
Ibritumomab tiuxetan Zevalin mab mouse CD20 Y non-Hodgkin's lymphoma Icrucumab mab human VEGFR-1 cancer etc. Idarucizumab Praxbind Fab humanized dabigatran
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Nilotinib
Class of enzymes
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Receptor_tyrosine_kinase
Monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Opicinumab
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Selpercatinib
Monoclonal antibody designed to treat X-linked hypophosphatemia
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Burosumab
Protein involved in blood vessel growth
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Vascular endothelial growth factor
Vascular_endothelial_growth_factor
Medication
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Trastuzumab_deruxtecan
Experimental monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Prasinezumab
Medication
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Idarucizumab
Transmembrane receptors involved in cellular adhesion and signalling
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Integrin
Medication which blocks growth of blood vessels
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Anti-VEGF
Medication
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Filgrastim
Medication and naturally occurring steroid hormone
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Testosterone_(medication)
Medication
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Trastuzumab
Class of drugs used to treat malignant tumors
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Antineoplastic
Pharmaceutical compound
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Abciximab
Monoclonal antibody medication
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Solanezumab
Monoclonal antibody
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Eptinezumab
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Prasterone_enanthate
Mammalian protein found in humans
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Nerve_growth_factor
Pharmaceutical drug
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Ranibizumab
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Dihexa
Pharmaceutical drug
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Cetuximab
Mammalian protein and protein-coding gene
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
KIT_gene
Protein-coding gene in mammals
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Fibroblast_growth_factor_21
Drug typically used in cancer treatment
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Tyrosine_kinase_inhibitor
Combination drug
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Pertuzumab/trastuzumab/hyaluronidase
Pertuzumab/trastuzumab/hyaluronidase
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Lenvatinib
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Encorafenib
Chemical compound, used as a medication to treat lung cancer
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Osimertinib
Medication
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Fruquintinib
Family of biomolecules
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Neurotrophic_factors
Experimental drug for neurodegenerative disorders
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Cerebrolysin
Medication
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Repotrectinib
Anticancer medication
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Trametinib
Gene involved in the most common form of dwarfism
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Fibroblast growth factor receptor 3
Fibroblast_growth_factor_receptor_3
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Tucatinib
Monoclonal antibody
Glembatumumab vedotin† Intetumumab§ Ipilimumab Iratumumab§ Istiratumab Icrucumab§ Lexatumumab§ Linvoseltamab Lucatumumab§ Mapatumumab§ Narnatumab§ Necitumumab
Minretumomab
Cancer medication
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Lapatinib
Veterinary medication
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Izenivetmab
Medication
Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab Mouse
Bentracimab
Protein family
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
VEGF_receptor
TrkA and TrkB positive modulator
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
ACD856
Monoclonal antibody
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Pegfilgrastim
Synthetic protein
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
IGF-1_LR3
Proteins similar to insulin that stimulate cell proliferation
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Insulin-like_growth_factor
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Axitinib
Cancer treatment medicine
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Sorafenib
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Dasatinib
Protein that stimulates cell division and differentiation
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Epidermal_growth_factor
Chemical compound
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Ponazuril
Group of protein families
Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept Others Additional
Neurotrophic_factor_receptor
travel, tourism, insurance
ICRUCUMAB
ICRUCUMAB
ICRUCUMAB
ICRUCUMAB
ICRUCUMAB
ICRUCUMAB
ICRUCUMAB
ICRUCUMAB
ICRUCUMAB
travel, tourism, insurance